Study highlights increased risk of second cancers among breast cancer survivors
Survivors of breast cancer are at significantly higher risk of developing second cancers, including endometrial…
Browsing: ovarian cancer
AACR 2024: Artificial intelligence analysis of DNA fragmentomes and protein biomarkers noninvasively detects ovarian cancer
A blood-based machine learning assay that combines cell-free DNA (cfDNA) fragment patterns and levels of…
Novel theranostic tool allows for noninvasive identification and treatment of ovarian cancer
A new radiotheranostic system has the ability to detect and treat ovarian cancer noninvasively, according…
Reducing the side effects of breast and ovarian cancer treatment
Some anti-cancer treatments not only target tumour cells but also healthy cells. If their effects…
Ovarian Cancer Research Foundation announces $2.4 million in new funding
Today, three ovarian cancer research institutions have received significant funding from the Ovarian Cancer Research…
Ovarian cancer: Targeting LTA4H improves the tumour immune microenvironment
In ovarian cancer, the abnormal expression of various metabolic enzymes in the metabolism of polyunsaturated…
Researchers develop test that could identify precancerous lesions on the fallopian tubes
Researchers at the Johns Hopkins Kimmel Cancer Center and the Department of Gynecology and Obstetrics…
BRCA1 and BRCA2 in a cohort of ovarian cancer patients from the Salento peninsula
A new research paper was published in Oncotarget’s Volume 15 on February 22, 2024, entitled, “Prevalence and spectrum…
Research identifies predictor of outcomes, chemoresistance for ovarian cancer patients
In a major scientific breakthrough, newly published research from an international consortium led by the…
Elenagen delays disease progression
CureLab Oncology, a clinical-stage, pre-IPO biotech company, announced that its novel biological agent, Elenagen, has…